Article

The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket Immunosuppressives

2024-08-29

Abstract excerpt

Lupus, also known as systemic lupus erythematosus (SLE), is a chronic autoimmune disease that can lead to inflammation and damage to multiple organs and tissues in the body. The symptoms vary from patient to patient, which makes the disease manifest very differently, resulting in difficulty in diagnosing and treating patients. Some may experience fatigue, hair loss, joint pain, and more. In the past, a general app...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 95d9fe28-9708-5220-91c8-64dbd2a3d4de
DOI: 10.20944/preprints202408.2116.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket ImmunosuppressivesDOI 10.20944/preprints202408.2116.v1Read

Efficacy and safety of belimumab in immune thrombocytopenia secondary to systemic lupus erythematosusSemantic proximity Read

Update οn the diagnosis and management of systemic lupus erythematosus.Semantic proximity Read

Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Semantic proximity Read

Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosusSemantic proximity Read

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseasesSemantic proximity Read

Investigation of novel therapeutic strategies in B cell and antibody mediated diseaseSemantic proximity Read

Novel biological therapeutic approaches to cutaneous lupus erythematosus.Semantic proximity Read

Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLESemantic proximity Read

Lupus nephritis: the evolving role of novel therapeutics.Semantic proximity Read

Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritisSemantic proximity Read

SLE is not a one-size-fits-all disease.Semantic proximity Read

Biologic therapies for lupus nephritis: a systematic review of efficacy, safety, and cost-effectivenessSemantic proximity Read